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AUTISM SPECTRUM DISORDERS
Autism is a complex neurobiological, developmental dis-
order that is typically diagnosed in childhood with symp-
toms that often last throughout a person’s lifetime. Autism 
is part of a group of disorders known as autism spectrum 
disorders (ASD), characterized by varying degrees of 
symptom severity and impact, ranging from mild to quite 
severe. The hallmark characteristics of autism include an 
impaired ability to communicate and relate to others so-
cially. Autism is also associated with a restricted range of 
activities and repetitive behaviors, such as obsessively ar-
ranging objects or following very specific routines.
ASD can usually be reliably diagnosed behaviorally by 24 
months of age although new and promising research aims to 
establish screening and diagnostic measures for children as 
young as 12-18 months1. While there is no known cure, re-
search indicates that early intervention in an appropriate ed-
ucational setting for at least two years during the preschool 
years can result in significant improvements in language, 
cognitive ability, and social skills for many young children 
with autism spectrum disorders2,3. 
ASD EPIDEMIOLOGY
The prevalence of ASD is not documented in many coun-
tries around the world, with most information coming 
from regions such as in Europe and the United States, 
where standardized diagnostic approaches are available. 
Despite some preliminary efforts4 there is not a reliable 
population-based prevalence estimate published in Bra-
zil, nor in any other Latin America country5. In the last 
two decades of epidemiological research, best-estimates 
of ASD prevalence ranged anywhere from 4/10,000 to 
6/1,0006. The most recent estimates of ASD prevalence in 
the U.S.7,8 and other Western nations9 indicate that almost 
1% of children are affected. Based on these international 
estimates, it is conceivable that as many as 1.5 million Bra-
zilians are currently living with ASD. 
While the apparent increase in ASD prevalence may be 
due in part to shifting diagnostic practices and increased 
awareness, these factors alone may not explain the entire 
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increase. Other risk factors that may be contributing to 
the increase in prevalence remain unknown and warrant 
further investigation10,11. What is known is that autism af-
fects far more individuals than previously imagined and 
the cost of autism is staggering. The economic cost of this 
disorder in the U.S. is close to $35 billion annually12. These 
numbers may be even higher in cases with co-morbid dis-
orders and autism.
The neurodevelopmental deficits underlying ASD are 
believed to transcend racial, ethnic, sociocultural, and 
geographic boundaries, thus there is increasing momen-
tum to examine autism internationally. Such investigation 
will begin to address the more perplexing epidemiologic 
questions surrounding autism including how prevalence 
varies between settings and what factors, either genetic or 
environmental, may influence the prevalence and pheno-
typic expression of ASD. However major barriers stand 
in the way of conducting research and providing services 
to those affected by autism around the world. Levels of 
awareness, research capacity, service availability, and local 
beliefs about behavioral differences differ markedly across 
countries. In addition, the burden autism presents on so-
ciety is unknown due to the absence of reliable epidemio-
logic data on prevalence. 
Well designed, robust epidemiological research is re-
quired to help professionals and governments identify au-
tism as a public health priority, and to provide a platform 
for autism policy reform. This is the case for Brazil. The 
guidelines of the Brazilian Public Health System (SUS) 
suggest that actions of public policy must be based on 
scientific evidence13. From a public health perspective, re-
search on ASD conducted in a particular country is very 
important to estimate the magnitude of ASD, its etiology, 
and how to plan strategies of intervention. The ultimate 
goal of autism research is to improve the care and the out-
comes for individuals with ASD and their family.
INTERNATIONAL LEADERSHIP
International organizations have played an important 
role in encouraging the recognition of autism and other 
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mental health issues worldwide, and in guiding local 
decision-makers on the development of necessary pub-
lic health policies. An interesting example is the current 
Grand Challenges in Global Mental Health (GCGMH), 
involving NIMH, WHO, London School, among other 
internationally recognized organizations. This consortium 
of international researchers is seeking consensus on the 
major barriers to improving research and provision of ser-
vices in autism and mental health around the globe.
For autism-specific activities, it is important to high-
light the efforts of Autism Speaks. Autism Speaks (AS) is 
the world’s largest autism science and advocacy organiza-
tion in the world, dedicated to changing the lives for all 
who struggle with autism by enhancing and supporting 
autism awareness, research and services worldwide. In 
2008, AS launched the Global Autism Public Health initia-
tive (GAPH), an ambitious international advocacy effort 
designed to: (1) enhance public and professional aware-
ness of autism; (2) increase clinical and scientific exper-
tise/capacity and promote international research collabo-
rations; and (3) enable service development and training 
in early detection and intervention around the world. The 
GAPH development process and content are informed by 
the latest findings in treatment research and by systematic 
knowledge translation. The aim is to accelerate the deliv-
ery of meaningful benefits to individuals and families by 
working collaboratively with all the stakeholders, includ-
ing health, education, and other government o cials, 
expert clinicians and scientists, as well as families in the 
community. In 2010, GAPH was introduced to the Brazil-
ian autism community at the First Brazilian Meeting for 
Autism Research.
AS has worked collaboratively with partners in Cen-
tral and South America, as well as the Middle East, Asia, 
and Africa on GAPH-related activities, including techni-
cal development, training, and awareness efforts. On the 
research side, more than 100 investigators from over 30 
countries currently participate in the International Autism 
Epidemiology Network (IAEN). A component of GAPH, 
the network promotes collaborative research by providing 
a forum for communication and idea exchange between 
epidemiologists from around the globe. Among the inves-
tigators who participate to IAEN and other GAPH efforts 
are those from Brazil. 
AS initiatives have facilitated meetings between Bra-
zilian and international investigators, promoting col-
laboration and idea sharing on how to address the autism 
research priorities in Brazil and around the world. One 
such example is the partnership between AS and the In-
ternational League Against Epilepsy (ILAE). As comor-
bid disorders are common among individuals with ASD, 
this has become an area of key concern and focus among 
the international autism research community. Epilepsy, 
for instance, has been estimated to affect 20%-40% of 
autism cases14. The AS-ILAE partnership aims to establish 
a bridge of communication between professionals working 
in ASD and those working in epilepsy to address common 
clinical and research objectives, and Brazil is also repre-
sented in this initiative.
AUTISM IN BRAZIL
A recent systematic review of the Brazilian scientific 
literature on ASD shed light on the current state of autism 
science in Brazil. On one hand, the review demonstrated a 
significant increase in the Brazilian autism scientific pro-
duction in the last two years. On the other hand, it showed 
that most of these publications are not focused on mat-
ters that contribute significantly to improving public 
health surrounding autism in Brazil. Most publications 
refer to uncontrolled intervention studies with small con-
venience samples, while epidemiological studies (a prev-
alence study, as a first step) and validation of diagnostic 
and neuropsychological instruments are almost nonexis-
tent. These efforts, as mentioned previously, are essential 
for guiding public policies around the magnitude of and 
response to the autism crisis. Another intriguing finding 
of this review was the extreme concentration of scientific 
production in only two Brazilian regions. Investigators 
from southeast (mainly São Paulo) and south (particularly 
Rio Grande do Sul) were first authors of almost 90% of all 
papers published between 2002-200915. 
The paucity of research utilizing more robust method-
ologies and the concentration of scientific production in 
a small number of regions throughout the country reflect 
the lack of specific funding for autism research in Brazil. 
An additional consequence of this situation is the lack 
of specialized human resources and a subsequent lack of 
services for affected individuals and their families. In this 
sense, the creation of centers of excellence, research con-
sortiums, and unified community/family associations, at 
national and international levels, are vital to enhancing 
autism research and services in Brazil.
BRAZILIAN MEETING FOR AUTISM RESEARCH - LEARNING 
FROM THE SCIENTIFIC AND AUTISM COMMUNITIES
In an effort to better understand the state of autism in 
Brazil, a first-of-its-kind event took place in April 2010: 
the 1st Brazilian Meeting for Autism Research (www.ufrgs.
br/ebpa2010). The meeting was a unique opportunity to 
disseminate results of Brazilian autism research to the 
scientific and parent communities as well as to promote 
networking and collaboration between international and 
Brazilian experts in clinical and basic sciences.
Over three days, speakers presented the latest results 
and new scientific knowledge about autism to an audi-
ence of over 400 participants. Brazilian Public Policy for 
autism was presented and discussed by government rep-
resentatives from the Brazilian Ministries of Health and 
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Education. In addition, Autism Speaks participated in the 
event and presented the Global Autism Public Health Ini-
tiative as an approach to enhancing research, services, and 
awareness that Brazil could contribute to. While most at-
tendees were autism investigators and professionals from 
the Health and Educational fields, there was also a strong 
presence from the autism advocacy community represent-
ing numerous Brazilian autism organizations as well as 
parents from across the country. These stakeholders had 
a special one day meeting to debate their needs and main 
barriers to achieve them, attended by over 100 parents. 
During the meeting, data was collected from speakers 
and stakeholders to identify current challenges and bar-
riers to autism research and services. This was an effort 
to define the consensus priorities around improving re-
search, awareness and services for autism in Brazil. It is 
envisioned that the following valuable information can be 
used by research and service professionals, policymakers, 
and/or community advocates to take more suitable deci-
sions for autism in Brazil.
The main challenges and barriers identified included:
t Lack of specific funding support for autism research
t Lack of well-trained investigators and clinicians in 
several disciplines
t Lack of multicenter national and international projects 
t Lack of robust scientific studies, relying on large 
sample sizes 
t Scientific evidence originates mostly from only two 
Brazilian States 
t Lack of awareness campaigns to enhance under-
standing among the general public and professionals 
in the health and education systems
The priority areas identified in response to these chal-
lenges were as follows:
1. Research
t Build capacity for research in diverse disciplines (e.g. 
epidemiology, psychology, genetics, etc.) through re-
search training programs around the country
t Promote clinical training, including training in di-
agnostic instruments, early detection and evidence 
based interventions
t Determine the prevalence of autism in Brazil to be 
used for public health policy planning
t Investigate the impact and success of national edu-
cation inclusion program in regular schools settings
t Implement strategies to achieve financial support 
from main Brazilian funding agencies (FAPESP, 
CAPES and CNPQ)
t Encourage collaboration between Brazilian investi-
gators, and between Brazilian investigators and in-
ternational experts.
2. Awareness
t Raise public understanding and improve public per-
ception of autism by making information more ac-
cessible to the public
t Address detection of children through the public 
systems, principally in primary care and school set-
tings;
t Address the needs for information on adolescent/
adult care and services
t Disseminate the latest key scientific findings to the 
Brazilian community
3. Services
t Enhance understanding of current approaches and 
best practices in service provision among Brazilian 
providers
t Build capacity for services in Brazil among profes-
sionals and in community-based settings
t Establish training program for screening early detec-
tion and intervention strategies, such as instruction 
to pediatricians and primary care clinicians.
CONCLUSIONS
As demonstrated by the success of the Brazilian Meeting for 
Autism Research as well as previous and ongoing research 
activities, there is much potential for Brazil to enhance its 
presence in the world of ASD research. In addition, Brazil 
can continue to be a leader in Latin America, producing 
high-quality and impactful ASD research. There is much 
research that remains to be completed in ASD research, 
and Brazil is in the unique position to address unanswered 
questions in autism epidemiology and etiology. For ex-
ample, the Brazilian population is highly diverse: 43% 
of the population is composed of persons of mixed race. 
Within this context, we would be able to explore associa-
tions between race and specific manifestations of the ASD. 
No studies are currently known which examine ASD in a 
mixed race population. 
Our first recommendation is that future Brazilian au-
tism research should be focused on understanding and 
improving issues related to public health. This includes 
developing guidelines to inform the SUS. In addition, the 
first population-based Brazilian prevalence study of ASD 
is crucial to inform public health policy. We expect that 
results from these activities will provide a solid foundation 
on which Brazilians can work together to address the chal-
lenges and barriers previously identified by experts and 
stakeholders in the Brazilian autism community.
Another key element to be addressed in the next few 
years is to increase clinical and scientific expertise, en-
compassing the various disciplines involved in the field of 
autism research and services. The creation of centers of 
excellence with the aim of training professionals in the 
areas of health and education is a demonstrated approach 
to enhancing professional capacity. Additionally, the es-
tablishment of national networks and unified associations 
would help accelerate the pace of scientific production by 
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galvanizing the Brazilian autism expert community. To-
gether, these activities can improve the understanding of 
autism in Brazil, Latin America, and around the world by 
contributing meaningful scientific knowledge to the field. 
At the same time, the Brazilian autism community will 
benefit from the added expertise and capacity to provide 
much needed autism diagnostic and intervention services 
to those affected individuals and their families. 
ASD cannot be considered a rare disorder anymore 
and over a million Brazilians are likely to be affected. The 
health and educational public systems must be prepared to 
assist this population in dire need of support. The above 
recommendations will start to address these challenges 
as well as begin to develop a sustainable system of service 
and research specialists in Brazil. Recent activities among 
Brazilian autism professionals including the 1st Brazilian 
Meeting for Autism Research should be seen as positive 
and forward movement in the effort to address autism in 
Brazil, however it is only scratching the surface of the ef-
forts still needing. It is important for the Brazilian commu-
nity to build on these efforts by supporting and investing 
in future autism research.
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